Abstract

MOLECULAR CHARACTERIZATION, CLINICAL MANAGEMENT AND DEVELOPMENT OF THE VACCINES AGAINST THE TARGETED VIRAL COMPONENTS OF COVID-19

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call